Clinical Trials Directory

Trials / Completed

CompletedNCT01367392

Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System

Confirmation of Clinical Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (actual)
Sponsor
ActiViews Ltd. · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to confirm the safety and effectiveness of the ActiSight™ Needle Guidance System with CT-guided percutaneous (through the skin) liver biopsies and ablations . The device used in this study is designed to assist the physician in guiding the needle towards the suspected area. This device does not change the procedure of liver biopsy or ablation. The only difference is that a small adhesive pad is placed on the skin and a miniature video camera is attached to the end of the needle. This camera does not enter the body.

Conditions

Interventions

TypeNameDescription
DEVICEbiopsy or ablationbiopsy or ablation performed as in standard of care with assistance of ActiSight Needle Guidance system

Timeline

Start date
2011-06-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2011-06-07
Last updated
2012-02-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01367392. Inclusion in this directory is not an endorsement.